HeartBeam Stock (NASDAQ: BEAT) stock price, news, charts, stock research, profile.
Open | $2.82 |
Close | $2.89 |
Volume / Avg. | 57.69K / 113.75K |
Day Range | 2.75 - 2.90 |
52 Wk Range | 1.06 - 3.39 |
Market Cap | $70.30M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 56 |
Short Interest | 1.19% |
Days to Cover | 3.6 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of HeartBeam (NASDAQ:BEAT) through any online brokerage.
Other companies in HeartBeam’s space includes: Pro-Dex (NASDAQ:PDEX), LENSAR (NASDAQ:LNSR), Asensus Surgical (AMEX:ASXC), Modular Medical (NASDAQ:MODD) and Lucid Diagnostics (NASDAQ:LUCD).
There is no analysis for HeartBeam.
HeartBeam has a consensus price target of $6.78.
The stock price for HeartBeam (NASDAQ: BEAT) is $2.67 last updated July 23, 2024 at 7:44 AM EDT.
There are no upcoming dividends for HeartBeam.
HeartBeam’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for HeartBeam.
HeartBeam is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.